Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Proteome Sciences plc. (10/31/16). "Press Release: Placing and Subscription of 66,258,100 New Ordinary Shares at 5 Pence perShare and Notice of General Meeting". 2016-10-31
Arix Bioscience plc. (10/31/16). "Press Release: Arix Bioscience Appoints Dr Franz B. Humer as Senior Independent Director". London. 2016-10-31
Freshfields Bruckhaus Deringer. (10/28/16). "Pressemitteilung: Krebstherapie – Freshfields berät Ganymed-Eigner beim Verkauf an Astellas Pharma". 2016-10-28
Freshfields Bruckhaus Deringer. (10/28/16). "Pressemitteilung: Freshfields berät Mologen AG bei Bezugsrechtskapitalerhöhung und Emission einer Wandelschuldverschreibung". 2016-10-28
Mercia Technologies plc. (10/27/16). "Press Release: Investment in Oxford Genetics Limited". 2016-10-27
AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA. 2016-10-27
Probiodrug AG. (10/27/16). "Press Release: Probiodrug to Present at European Life Sciences Conferences. Attendance at Key Conferences in November 2016". Halle (Saale). 2016-10-27
Genomics Medicine Ireland Ltd.. (10/26/16). "Press Release: Genomics Medicine Ireland Raises $40 Million in Series A Funding". Dublin. 2016-10-26
Eurofins Scientific UK. (10/24/16). "Press Release: Eurofins Acquires International Laboratory Services Ltd". 2016-10-24
Mundipharma International Ltd.. (10/19/16). "Press Release: Results from the NOR-SWITCH Study Support Switch from Remicade to Remsima (biosimilar infliximab)". Cambridge. 2016-10-19
Markes International Ltd.. (10/18/16). "Press Release: Markes International Enhances Its Suite of Thermal Desorption Products with New Sorptive Extraction Technology". Llantrisant. 2016-10-18
Jefferies Group LLC. (10/18/16). "Press Release: Jefferies to Host 2016 London Healthcare Conference". London. 2016-10-18
Arquer Diagnostics Ltd.. (10/18/16). "Press Release: Arquer Diagnostics and the University of Sunderland Collaborate to Extend Application of Cancer Diagnostic". Sunderland. 2016-10-18
Arquer Diagnostics Ltd.. (10/18/16). "Press Release: Arquer Diagnostics Appoints Nadia Whittley as CEO". Sunderland. 2016-10-18
Ergomed plc. (10/14/16). "Press Release: Ergomed’s Co-development Partner Aeterna Zentaris, Inc. Announces a Fourth Licensing Agreement for Zoptrex". London. 2016-10-14
PhoreMost Ltd.. (10/12/16). "Press Release: PhoreMost Ltd and University of Cambridge Collaborate to Identify Innovative Drug Targets for Neurodegenerative Disease". Cambridge. 2016-10-12
Immunocore Ltd.. (10/12/16). "Press Release: Immunocore Appoints Paul Fry as Chief Financial Officer". Oxford. 2016-10-12
Oxford Immunotec Global plc. (10/12/16). "Press Release: Oxford Immunotec Acquires Immunetics, Inc.". Oxford & Marlborough, MA. 2016-10-12
Adaptimmune Therapeutics plc. (10/12/16). "Press Release: Adaptimmune Provides Update on Clinical Study Evaluating Its SPEAR T-Cell Therapy Targeting NY-ESO-1 in Ovarian Cancer". Philadeliphia, PA & Oxford. 2016-10-12
Midatech Pharma plc. (10/11/16). "Press Release: Results of Placing to raise £16.0 million and PDMR Shareholding [Not for United States, Canada, Australia, South Africa, Japan, New Zealand, et al.]". 2016-10-11
Kymab Ltd.. (10/11/16). "Press Release: Bispecific Antibody Agreement with EpimAb". 2016-10-11
Arcis Biotechnology Ltd.. (10/11/16). "Press Release: Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood". Daresbury. 2016-10-11
Crescendo Biologics Ltd.. (10/10/16). "Press Release: Crescendo Biologics and Takeda Enter Collaboration for Humabody-based Therapeutics Worth up to $790m". Cambridge & Osaka. 2016-10-10
Malin Corporation plc. (10/7/16). "Press Release: Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team". Dublin. 2016-10-07
Syncona LLP. (10/5/16). "Press Release: Achilles Therapeutics Launched with Funds of £13.2 Million to Develop Immunotherapies for Cancer". 2016-10-05
Owlstone Medical. (10/4/16). "Press Release: Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer". Cambridge. 2016-10-04
Healx Ltd.. (10/4/16). "Press Release: Healx Announces £1.5m Investment Led by Jonathan Milner". 2016-10-04
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. 2016-10-03
ReViral Ltd.. (10/3/16). "Press Release: ReViral Announces Appointment of New Chief Executive Officer". London. 2016-10-03
Prothena Corporation plc. (10/3/16). "Press Release: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director". Dublin. 2016-10-03
AstraZeneca plc. (9/30/16). "Press Release: AstraZeneca Presents New Data on Faslodex in Breast Cancer and Provides Immuno-oncology Update at ESMO 2016 Congress". 2016-09-30
DNA Electronics Ltd.. (9/30/16). "Press Release: BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza". London & Carlsbad, CA. 2016-09-30
GlaxoSmithKline plc. (9/29/16). "Press Release: GlaxoSmithKline plc Appoints Brian McNamara as CEO of GSK Consumer Healthcare". London. 2016-09-29
Atlantic Healthcare plc. (9/29/16). "Press Release: Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer". Cambridge & Raleigh, NC. 2016-09-29
AstraZeneca plc. (9/28/16). "Press Release: AstraZeneca Appoints David Goldstein as Chief Adviser for Its Genomics Initiative". 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Announces Intention to Sell Remaining Holding in Aspen". London. 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Completes Sale of Remaining Aspen Shares". London. 2016-09-28
Microsaic Systems plc. (9/28/16). "Press Release: Retirement of Chairman". 2016-09-28
Adaptimmune Therapeutics plc. (9/26/16). "Press Release: MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers". Philadeliphia, PA, Houston, TX & Oxford. 2016-09-26
Ergomed plc. (9/26/16). "Press Release: Unaudited Interim Results for the Six Months ended 30 June 2016". Guildford. 2016-09-26
Genomics England Ltd.. (9/23/16). "Press Release: GenomOncology’s Knowledge Management System to Analyse Cancer Samples in the 100,0000 Genomes Project". 2016-09-23
Ergomed plc. (9/22/16). "Press Release: Ergomed’s Full Service Contract Win Validates Strategic Rationale of Recent Acquisitions". London. 2016-09-22
Owlstone Medical. (9/22/16). "Press Release: Owlstone Medical Commences Next Phase in World’s Largest Breath-based Clinical Trial for Early Cancer Detection". Cambridge. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Proteome Sciences plc. (9/22/16). "Press Release: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease". Cobham. 2016-09-22
Artios Pharma Ltd.. (9/21/16). "Press Release: Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies". Cambridge. 2016-09-21
Imperial Innovations Group plc. (9/21/16). "Press Release: Innovations Invests £5.1m in Artios Pharma Limited". 2016-09-21
Orchard Therapeutics Ltd.. (9/21/16). "Press Release: Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresse 2016-09-21
GlaxoSmithKline plc. (9/20/16). "Press Release: Emma Walmsley to Succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline". London. 2016-09-20
Adaptimmune Therapeutics plc. (9/19/16). "Press Release: Adaptimmune Announces Strategic Manufacturing Agreement with PCT to Support Development of SPEAR T-cell Therapies Towards Commercialization". Philadeliphia, PA & Oxford. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada (alemtuzumab) in Clinical Trials". Paris. 2016-09-16
Abingworth LLP. (9/16/16). "Press Release: GammaDelta Therapeutics Raises Seed Funding from Abingworth". 2016-09-16
Merck KGaA. (9/16/16). "Press Release: Merck Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis". Darmstadt. 2016-09-16
PsiOxus Therapeutics Ltd.. (9/16/16). "Press Release: PsiOxus Therapeutics Announce Executive Team Reorganization with Two New C Level Appointments in the US". Oxford. 2016-09-16
Proteome Sciences plc. (9/15/16). "Press Release: Interim Results. Proteome Sciences Today Releases Its Unaudited Interim Results for the Six Months Ended 30th June 2016". 2016-09-15
Loughborough University. (9/15/16). "Press Release: Loughborough Researchers Develop Simple Saliva Test to Diagnose Asthma". 2016-09-15
Merck KGaA. (9/12/16). "Press Release: Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif at the 2016 ECTRIMS Congress". Darmstadt. 2016-09-12
Microsaic Systems plc. (9/12/16). "Press Release: Result of General Meeting, Completion of Placing and Total Voting Rights". 2016-09-12
Kymab Ltd.. (9/9/16). "Press Release: Kymab's Early Steps Towards HIV Vaccine". Cambridge. 2016-09-09
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Adaptimmune Therapeutics plc. (9/8/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-09-08
Horizon Discovery Group plc. (9/6/16). "Press Release: Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases". Cambridge. 2016-09-06
Peak Scientific Instruments Ltd.. (9/1/16). "Press Release: Peak Introduces Solaris Nitrogen – Gas Solution for ELSD & Compact MS Applications". 2016-09-01
MRC Technology. (9/1/16). "Press Release: New Collaboration to Explore Novel Treatments for Respiratory Diseases". London. 2016-09-01
Oxford Immunotec Global plc. (9/1/16). "Press Release: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation". Oxford & Marlborough, MA. 2016-09-01
Horizon Discovery Group plc. (9/1/16). "Press Release: Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards". Cambridge. 2016-09-01
Phagenesis Ltd.. (9/1/16). "Press Release: The Staged Acquisition of Phagenesis by Nestlé Health Science Will Benefit Patients with Dysphagia". Manchester. 2016-09-01
Roche. (9/1/16). "Press Release: Phase III Efficacy Results of Investigational Medicine Ocrevus (ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis". Basel. 2016-09-01
Microsaic Systems plc. (8/26/16). "Press Release: Interim Results and Management Update for the Six Months Ended 30 June 2016". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Result of Placing". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Proposed Placing of up to 108,000,000 New Ordinary Shares at 5 Pence per Share and Notice of General Meeting". 2016-08-26
SpectralWorks Ltd.. (8/26/16). "Press Release: SpectralWorks Releases AnalyzerPro Version 5.3". 2016-08-26
Cyprotex plc. (8/25/16). "Press Release: Cyprotex Install Two AB Sciex TripleTOF 6600 Mass Spectrometer Systems". 2016-08-25
AstraZeneca plc. (8/24/16). "Press Release: AstraZeneca to Sell Small Molecule Antibiotics Business to Pfizer. Value-creating Divestment Supports AstraZeneca’s Focus on Three Main Therapy Areas". 2016-08-24
Oxford Immunotec Global plc. (8/24/16). "Press Release: Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference". Oxford & Marlborough, MA. 2016-08-24
GE Healthcare. (8/23/16). "Press Release: GE Healthcare Expands Cell Therapy Portfolio with License of Stemcell Technologies’ T-Cell Reagents". Chalfont St. Giles. 2016-08-23
AstraZeneca plc. (8/22/16). "Press Release: AstraZeneca and Lilly Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer’s Disease". 2016-08-22
Consilium Strategic Communications Ltd.. (8/22/16). "Press Release: Consilium Strategic Communications Advises Cambridge Innovation Capital on Its £75m Fundraise". 2016-08-22
Bayer AG. (8/19/16). "Press Release: Bayer and CRISPR Therapeutics Joint Venture, Named Casebia Therapeutics, Establishes Operations in Cambridge, MA". Leverkusen & Basel. 2016-08-19
Cambridge Innovation Capital plc. (8/19/16). "Press Release: Cambridge Innovation Capital Raises £75 Million via Private Financing". 2016-08-19
Excivion Ltd.. (8/18/16). "Press Release: Excivion Ltd. Announces Collaboration with Xenetic Biosciences, US, to Develop a Novel Combined Zika and Dengue Vaccine". Cambridge. 2016-08-18
Indivior plc. (8/17/16). "Press Release: Indivior Announces Positive Top-line Phase 3 Pivotal Study Results for RBP-6000 Buprenorphine Monthly Depot for the Treatment of Opioid Use Disorder". Slough, UK. 2016-08-17
GlaxoSmithKline plc. (8/16/16). "Press Release: ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment". 2016-08-16
Peak Scientific Instruments Ltd.. (8/10/16). "Press Release: Peak Scientific Introduces Innovative Gas Subscription Service. New FlexFlow Service Offers the Benefits of a Generator with a Monthly Rental Cost". 2016-08-10
AstraZeneca plc. (8/9/16). "Press Release: AstraZeneca Provides Update on Phase III Trial of Selumetinib in Non-small Cell Lung Cancer". 2016-08-09
Adaptimmune Therapeutics plc. (8/8/16). "Press Release: Adaptimmune Reports Second Quarter 2016 Financial Results". Philadeliphia, PA & Oxford. 2016-08-08
Chronos Therapeutics Ltd.. (8/4/16). "Press Release: Chronos Therapeutics Strengthens Management Team with Appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl as Vice Presidents of Pre-Clinical Development". Oxford. 2016-08-04
Repositive. (8/4/16). "Press Release: Repositive Launches Consortium with AstraZeneca to Improve Oncology Research". Cambridge. 2016-08-04
AMETEK, Inc.. (8/4/16). "Press Release: AMETEK Completes Two Acquisitions. Nu Instruments Adds to Position in High-End Elemental Analysis – HS Foils Brings Unique Technology to Materials Analysis Business". Berwyn, PA. 2016-08-04
Adaptimmune Therapeutics plc. (8/3/16). "Press Release: Adaptimmune Announces Partial Clinical Hold of Planned Pivotal Study of NY-ESO SPEAR T-cell Therapy in Myxoid Round Cell Liposarcoma". Philadeliphia, PA & Oxford. 2016-08-03
Oxford Immunotec Global plc. (8/2/16). "Press Release: Oxford Immunotec Reports Second Quarter 2016 Financial Results". Oxford & Marlborough, MA. 2016-08-02
GlaxoSmithKline plc. (8/1/16). "Press Release: GSK and Verily to Establish Galvani Bioelectronics – a New Company Dedicated to the Development of Bioelectronic Medicines". 2016-08-01
Cosmo Pharmaceuticals N.V.. (7/29/16). "Press Release: Cosmo Reports Growth in Product Revenues and Progress in Late Stage Product and Corporate Development". Dublin. 2016-07-29
Adaptimmune Therapeutics plc. (7/28/16). "Press Release: Adaptimmune Receives Access to Priority Medicines (PRIME) Regulatory Support for its SPEAR® T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-07-28
Selvita S.A.. (7/28/16). "Press Release: Epidarex Capital Creates Nodthera Limited". Edinburgh. 2016-07-28
Proteome Sciences plc. (7/28/16). "Press Release: Trading Update and Notice of Results". 2016-07-28
GlaxoSmithKline plc. (7/27/16). "Press Release: GSK Announces Significant New Investment in UK Manufacturing Network. Total of £275 million to Be Invested". 2016-07-27
GlaxoSmithKline plc. (7/27/16). "Press Release: GSK In-licenses anti-IL-33R Monoclonal Antibody for Severe Asthma from Janssen". London. 2016-07-27
GlaxoSmithKline plc. (7/27/16). "Press Release: Results Announcement for the Second Quarter 2016 and Half-yearly Financial Report for the Half-year 2016". 2016-07-27
Adaptimmune Therapeutics plc. (7/26/16). "Press Release: Adaptimmune Receives Orphan Drug Designation in the European Union for its NY-ESO SPEAR T-cell Therapy for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-07-26
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top